2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Cheng, X; Hu, L; Kok, SHL; Lee, KKH; Li, K; Li, P; Lin, L; Qian, F; Song, J; Yang, X; You, L; Zhu, L | 1 |
| Cho, IA; Chun, HS; Kang, KR; Kim, CS; Kim, DK; Kim, HJ; Kim, JS; Kim, TH; Lee, SA; Lim, H; Moon, SM; Yu, SK | 1 |
2 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Reversine suppresses osteosarcoma cell growth through targeting BMP-Smad1/5/8-mediated angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Bone Morphogenetic Proteins; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chick Embryo; G1 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; Morpholines; Neovascularization, Physiologic; Osteosarcoma; Purines; Signal Transduction; Smad Proteins; Smad1 Protein; Smad2 Protein; Smad3 Protein | 2021 |
Reversine induces caspase-dependent apoptosis of human osteosarcoma cells through extrinsic and intrinsic apoptotic signaling pathways.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Humans; Morpholines; Osteosarcoma; Purines; Signal Transduction | 2019 |